yomogin has been researched along with calcitriol in 1 studies
| Studies (yomogin) | Trials (yomogin) | Recent Studies (post-2010) (yomogin) | Studies (calcitriol) | Trials (calcitriol) | Recent Studies (post-2010) (calcitriol) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 16,107 | 1,224 | 3,710 |
| Protein | Taxonomy | yomogin (IC50) | calcitriol (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0093 | |
| Vitamin D3 receptor | Homo sapiens (human) | 0.3401 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0093 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH; Kim, TS | 1 |
1 other study(ies) available for yomogin and calcitriol
| Article | Year |
|---|---|
Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
Topics: Antineoplastic Agents; Artemisia; Calcitriol; Cell Differentiation; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescent Antibody Technique; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nitric Oxide Synthase; Phytotherapy; Sesquiterpenes; Sesquiterpenes, Eudesmane; Tretinoin | 2002 |